Skip to main navigation Skip to search Skip to main content

SHORT-TERM ADHERENCE OF URATE-LOWERING AGENTS WILL NOT IMPROVE END-STAGE RENAL DISEASE AND MORTALITY

    Research output: Contribution to journal › Journal Article › peer-review

    Original languageAmerican English
    Pages (from-to)446-447
    JournalAnnals of the Rheumatic Diseases
    Volume79
    DOIs
    StatePublished - 2020

    Cite this